Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2024.03.15
ag真人平台官方：关于收到实际控制人先行垫付款项的公告
2024.03.15
DATE OF BOARD MEETING
2024.03.15
INSIDE INFORMATION ANNOUNCEMENT
2024.02.05
ag真人平台官方：关于深圳证监局对公司采取责令改正措施决定的公告
2024.02.05
ag真人平台官方：第六届监事会第五次会议决议公告
2024.02.05
ag真人平台官方：第六届董事会第八次会议决议公告
2024.02.05
ag真人平台官方：关于深圳证监局对公司采取责令改正措施决定的整改报告
2024.02.01
INSIDE INFORMATION ANNOUNCEMENT COMMENCEMENT OF INDEPENDENT THIRD PARTY INVESTIG...
2024.02.01
PROFIT WARNING ANNOUNCEMENT OF PROPOSED PROVISION FOR INVENTORY IMPAIRMENT IN 20...
2024.02.01
ESTIMATED ANNUAL RESULTS FOR 2023
第一页
上一页
4
5
6
7
8
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
